Genotyping Testing for HIV Tropism: Screening for Co-Receptor Antagonist Therapy



About this Webinar

Date: Wednesday, March 14, 2012

Author: Harrigan, Richard, PhD
Director, Research Laboratories
British Columbia Centre for Excellence in HIV/AIDS
Vancouver, British Columbia
Also by this Author 

Category: Webinar

Description: Richard Harrigan, PhD discusses the clinical utility of genotypic testing for HIV tropism, compares genotypic and phenotypic testing methods, and explores the future potential of genetic “deep sequencing” for genotypic tropism testing and other applications.
Learning Objectives - at the conclusion of this program, participants will be able to:
o Define HIV tropism and its importance for CCR5 co-receptor antagonist therapy
o Compare the two principal methods for testing for HIV tropism - phenotyping and genotyping
o Describe how genotypic tropism test results are interpreted
o Discuss the role of "deep sequencing” in genotypic tropism testing